Toxicity of ecstasy (MDMA) towards embryonic stem cell-derived cardiac and neural cells

Toxicol In Vitro. 2010 Jun;24(4):1133-8. doi: 10.1016/j.tiv.2010.03.005. Epub 2010 Mar 15.

Abstract

"Ecstasy" or methylenedioxymethamphetamine (MDMA) is primarily a recreational drug commonly used during the child bearing period, thus, there is a major concern regarding the embryonic and fetal toxicity of this drug. Here, we report the cardio- and neuro-toxic effects of MDMA on beating embryoid bodies (EBs) and neural cell-containing EBs derived from mouse embryonic stem cell (ESCs). Based on our linear discriminate function, MDMA is considered to be a moderate or weak teratogen. Moreover, the generation of EBs with neural cell morphology and the expression of MAP2, a mature neuron marker, decrease more when MDMA is administered during the EB formation stage rather than post-plated EBs. In addition, the ID50 (inhibition of differentiation) of EBs with neural cell morphology is less than cardiac cells. In conclusion, MDMA causes a marked reduction in beating cardiomyocytes and neurons in ESC cultures, and this drug has a more potent toxicity on neural rather than cardiac cell differentiation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cardiotoxins / toxicity
  • Cell Differentiation / drug effects
  • Cell Line
  • Embryonic Stem Cells / drug effects*
  • Fetus / drug effects
  • Hallucinogens / toxicity*
  • Illicit Drugs / toxicity
  • Mice
  • Mice, Inbred C57BL
  • Myocytes, Cardiac / drug effects*
  • N-Methyl-3,4-methylenedioxyamphetamine / toxicity*
  • Neurons / drug effects*
  • Neurotoxins / toxicity
  • Toxicity Tests

Substances

  • Cardiotoxins
  • Hallucinogens
  • Illicit Drugs
  • Neurotoxins
  • N-Methyl-3,4-methylenedioxyamphetamine